OHSU, Casey Eye Institute

Portland, Oregon 97239

2 studies enrolling now · 10 studies all time

What they study most

Amblyopia, Choroideremia, Exotropia Intermittent, Neurotrophic Keratopathy, Non-Infectious Uveitis, Non-infectious Uveitis, Proliferative Vitreoretinopathy, Retinitis Pigmentosa 39, Usher Syndrome, Type 2A, X-Linked Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP)

Studies at this site

• Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age — Recruiting now
• Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 — Recruiting now
• Rate of Progression in USH2A-related Retinal Degeneration — Running, not enrolling
• Binocular Dig Rush Game Treatment for Amblyopia — Completed
• Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa — Completed
• A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa — Running, not enrolling
• The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy — Completed
• Base-in Prism Spectacles for Intermittent Exotropia — Completed
• Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert — Completed
• Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis — Stopped early